Date:11/5/2009

36 ========= ========= ========= ========= Diluted $0.15 $0.07 $0.59 $0.36 ========= ========= ========= ========= Weighted average common shares and equivalent shares outstanding: Basic 35,326 35,174 35,289 35,161 Diluted 35,620 35,402 35,486 35,354 Symmetry Medical Reports Third Quarter 2009 Financial Results Consolidated Balance Sheets October 3, January 3, 2009 2009 -------- -------- (In Thousands) (unaudited) Assets: Current Assets: Cash and cash equivalents $16,432 $10,191 Accounts receivable, net 43,205 52,845 Inventories 65,697 61,111 Refundable income taxes 2,884 6,610 Deferred income taxes 5,493 3,993 Other current assets 2,710 3,154 -------- -------- Total current assets 136,421 137,904 Property and equipment, net 116,933 115,045 Goodwill 153,721 153,521 Intangible assets, net of accumulated amortization 43,387 45,039 Other assets 1,260 1,728 -------- -------- Total Assets $451,722 $453,237
'/>"/>

SOURCE Symmetry Medical Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Symmetry Medical Updates Full Year 2009 Financial Guidance
2. Symmetry Medical to Report Third Quarter 2009 Financial Results on November 5, 2009
3. Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
4. Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products
5. ATS Medical to Participate in the 2009 Canaccord Adams Cardiovascular Conference
6. CMS Admits New Surety Bond and Accreditation Requirement for Home Medical Equipment Suppliers Creating Patient Access Issues
7. AACE Issues New Medical Guidelines for Proper and Ethical Use of Growth Hormone
8. Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutritional Supplies and "Arthritis Kits"
9. Medical Imaging Solutions Firm Dicom Solutions Ranks No. 109 on the Inc. 500
10. ATS Medical Announces Third Quarter 2009 Results
11. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in the United States to Utilize Newly FDA-Cleared CARTO(R) 3 Navigation System